- Home
- UFG vs STRO Comparison
UFG vs STRO Comparison
Compare UFG & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFG
- STRO
- Stock Information
- Founded
- UFG 2021
- STRO 2003
- Country
- UFG Singapore
- STRO United States
- Employees
- UFG N/A
- STRO N/A
- Industry
- UFG Oil Refining/Marketing
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UFG Energy
- STRO Health Care
- Exchange
- UFG Nasdaq
- STRO Nasdaq
- Market Cap
- UFG 64.8M
- STRO 77.7M
- IPO Year
- UFG 2025
- STRO 2018
- Fundamental
- Price
- UFG $2.44
- STRO $0.80
- Analyst Decision
- UFG
- STRO Hold
- Analyst Count
- UFG 0
- STRO 7
- Target Price
- UFG N/A
- STRO $3.97
- AVG Volume (30 Days)
- UFG 257.0K
- STRO 833.9K
- Earning Date
- UFG 01-01-0001
- STRO 08-12-2025
- Dividend Yield
- UFG N/A
- STRO N/A
- EPS Growth
- UFG N/A
- STRO N/A
- EPS
- UFG 0.01
- STRO N/A
- Revenue
- UFG $155,193,013.00
- STRO $66,434,000.00
- Revenue This Year
- UFG N/A
- STRO N/A
- Revenue Next Year
- UFG N/A
- STRO N/A
- P/E Ratio
- UFG $460.92
- STRO N/A
- Revenue Growth
- UFG 119.24
- STRO N/A
- 52 Week Low
- UFG $1.15
- STRO $0.52
- 52 Week High
- UFG $6.13
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- UFG N/A
- STRO 46.11
- Support Level
- UFG N/A
- STRO $0.76
- Resistance Level
- UFG N/A
- STRO $0.94
- Average True Range (ATR)
- UFG 0.00
- STRO 0.07
- MACD
- UFG 0.00
- STRO -0.01
- Stochastic Oscillator
- UFG 0.00
- STRO 29.11
About UFG Uni-Fuels Holdings Limited Class A Ordinary Shares
Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.